95 related articles for article (PubMed ID: 359120)
1. Improvement of in vitro mitogen proliferative responses in non-Hodgkin's lymphoma patients exposed to fractionated total body irradiation.
Yonkosky DM; Feldman MI; Cathcart ES; Kim S
Cancer; 1978 Sep; 42(3):1204-10. PubMed ID: 359120
[TBL] [Abstract][Full Text] [Related]
2. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
3. Total body irradiation as a primary therapy in non-Hodgkin lymphoma.
Qasim MM
Clin Radiol; 1979 May; 30(3):287-6. PubMed ID: 378510
[TBL] [Abstract][Full Text] [Related]
4. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
Twomey JJ; Laughter AH; Lazar S; Douglass CC
Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
[TBL] [Abstract][Full Text] [Related]
5. Total body irradiation in non-Hodgkin's lymphoma.
Thar TL; Million RR
Cancer; 1978 Aug; 42(2 Suppl):926-31. PubMed ID: 99225
[No Abstract] [Full Text] [Related]
6. Mitogen induced blood lymphocyte DNA synthesis as a prognostic indicator in patients with non-Hodgkin's lymphomas in clinical remission.
Lindemalm CS; Björkholm M; Holm G; Johansson B; Mellstedt H
Acta Radiol Oncol; 1983; 22(6):455-9. PubMed ID: 6328876
[TBL] [Abstract][Full Text] [Related]
7. The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Baral E; Blomgren H; Juhlin I
Cancer; 1979 Oct; 44(4):1241-6. PubMed ID: 498012
[TBL] [Abstract][Full Text] [Related]
8. On the question of the tumoricidal dose in non-Hodgkin's lymphomas.
Musshoff K; Leopold H
Recent Results Cancer Res; 1978; 65():203-6. PubMed ID: 106447
[No Abstract] [Full Text] [Related]
9. Rosette and blastogenesis inhibition by plasma from Hodgkin's disease and other malignancies. Positive correlation in State I and II Hodgkin's disease.
Sinclair T; Ezdinli EZ; Boonlayangoor P; Wasser LP; Han T
Cancer; 1983 Jan; 51(2):238-44. PubMed ID: 6336976
[TBL] [Abstract][Full Text] [Related]
10. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
Brubaker DB; Whiteside TL; Hartsock RJ
Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
[TBL] [Abstract][Full Text] [Related]
11. Total body irradiation in non-Hodgkin lymphoma.
Qasim MM
Strahlentherapie; 1975 Apr; 149(4):364-7. PubMed ID: 1094593
[TBL] [Abstract][Full Text] [Related]
12. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
13. Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.
Fisher RI; DeVita VT; Bostick F; Vanhaelen C; Howser DM; Hubbard SM; Young RC
Ann Intern Med; 1980 May; 92(5):595-9. PubMed ID: 6992672
[TBL] [Abstract][Full Text] [Related]
14. Lymphomas: initial reactivation.
Knapp WT; Fayos JV
Radiology; 1975 Dec; 117(3 Pt 1):695-700. PubMed ID: 1103230
[TBL] [Abstract][Full Text] [Related]
15. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
16. Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma.
Choi NC; Timothy AR; Kaufman SD; Carey RW; Aisenberg AC
Cancer; 1979 May; 43(5):1636-42. PubMed ID: 582159
[No Abstract] [Full Text] [Related]
17. Non-Hodgkin's lymphomas. 3. Preliminary results of radiotherapy and a proposal for new clinical trials.
Jones SE; Kaplan HS; Rosenberg SA
Radiology; 1972 Jun; 103(3):657-62. PubMed ID: 4553978
[No Abstract] [Full Text] [Related]
18. [Primary extranodal non-Hodgkin's lymphoma of the head and neck].
Festini G; Longaro F; Volpe C
Recenti Prog Med; 1997 Apr; 88(4):169-72. PubMed ID: 9206813
[TBL] [Abstract][Full Text] [Related]
19. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation.
Tsai D; Moore H; Hardy C; Porter D; Loh E; Vaughn D; Luger S; Schuster S; Stadtmauer E
Bone Marrow Transplant; 1999 Sep; 24(5):521-6. PubMed ID: 10482937
[TBL] [Abstract][Full Text] [Related]
20. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
